Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Virus-specific T Cells”

339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 339 results

Early research (Phase 1)Study completedNCT02973113
What this trial is testing

Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)

Who this might be right for
NonHodgkin LymphomaLymphoproliferative DisordersEBV Related Lymphoma+4 more
Baylor College of Medicine 8
Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Not applicableStudy completedNCT05713513
What this trial is testing

Manufacture of Clinical T-cell Products for Future Treatment

Who this might be right for
Virus-specific T Cells
University Hospital, Basel, Switzerland 9
Early research (Phase 1)Study completedNCT01535885
What this trial is testing

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

Who this might be right for
Epstein-Barr Virus InfectionsAdenovirusCytomegalovirus Infections
Medical College of Wisconsin 25
Early research (Phase 1)Active Not RecruitingNCT01953900
What this trial is testing

IC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma

Who this might be right for
OsteosarcomaNeuroblastoma
Baylor College of Medicine 26
Not applicableActive Not RecruitingNCT04565067
What this trial is testing

Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans

Who this might be right for
COVID-19
National Institute on Aging (NIA) 83
Not applicableStudy completedNCT01534728
What this trial is testing

Identification of Hepatitis C Virus (HCV) Specific T Cells

Who this might be right for
Hepatitis C
Institut National de la Santé Et de la Recherche Médicale, France 40
Early research (Phase 1)Study completedNCT00088868
What this trial is testing

17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 40
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Testing effectiveness (Phase 2)WithdrawnNCT02346617
What this trial is testing

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Who this might be right for
Cytomegalovirus Infections
Yae-Jean Kim
Testing effectiveness (Phase 2)Study completedNCT00711035
What this trial is testing

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
Adenovirus InfectionEBV Infection
Baylor College of Medicine 50
Testing effectiveness (Phase 2)Ended earlyNCT00949117
What this trial is testing

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

Who this might be right for
LeukemiaLymphomaMalnutrition+3 more
University of South Florida 9
Early research (Phase 1)Study completedNCT01460901
What this trial is testing

Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Mercy Hospital Kansas City 5
Testing effectiveness (Phase 2)Looking for participantsNCT06990087
What this trial is testing

T-cell Therapy in Patients With PML

Who this might be right for
Progressive Multifocal Leucoencephalopathy (PML)
Hannover Medical School 23
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)Looking for participantsNCT04197596
What this trial is testing

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Who this might be right for
Viral InfectionPrimary Immune Deficiency Disorder
New York Medical College 40
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Early research (Phase 1)Looking for participantsNCT06885710
What this trial is testing

HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Changhai Hospital 19
Early research (Phase 1)Study completedNCT00005021
What this trial is testing

Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Fox Chase Cancer Center 17
Load More Results